MedTrace Logo

Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.

NCT00761982 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-11-29

No results posted yet for this study

Summary

The aim of the study is to determine the safety and efficacy on an autologous CD34+ subset bone marrow stem cell infusion into the middle cerebral artery in patients who have suffered acute middle cerebral artery stroke.

Conditions

  • Stroke, Acute
  • Infarction, Middle Cerebral Artery

Interventions

PROCEDURE

Infusion on autologous CD34+ stem cells into middle cerebral artery

Intraarterial infusion of autologous bone marrow stem cells into middle cerebral artery of acute stroke patients

Sponsors & Collaborators

  • Hospitales Universitarios Virgen del Rocío

    collaborator OTHER

  • Hospital Universitario Central de Asturias

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00761982 on ClinicalTrials.gov